• English
  • Deutsch
Skip to content
Endotherm | Referenzsubstanzen | Arzneimittelforschung
  • Start
  • Custom Synthesis
    • Medicinal chemistry
    • Clinical chemistry
    • Drug approvals
  • Products
    • cat
      • Vitamin D metabolites
      • Isotopically labeled compounds
      • Active pharmaceutical ingredients and intermediates
      • Natural products
      • Coenzyme A esters
      • Steroids
      • Dyes
      • Retinal analogs
    • cat
      • Sulfoximines
      • Compound libraries
      • Antibiotic targets, and modulators
      • Polyphenols and derivatives
      • Heart disease target modulators
      • Diversified compound libraries
      • Miscellaneous
  • Research
    • New drugs to treat heart diseases
    • New drugs to treat infectious diseases
    • New drugs to treat kidney diseases
    • New drugs to treat mental health disorders
  • Company
    • Profile
    • Equipment
    • Quality first!
    • Publications
    • Patents
    • Events and Awards
  • Contact

Patents

Patents

2024-2013

2024

WO 2024105018 A1
"Novel pyrrolo[1,2-d][1,2,4]trizinone derivatives as negative allosteric modulators of mGlu7 receptors"

2022

WO 2022238579 A1 
„Substituted heterocyclic derivatives as negative allosteric modulators of mGlu7 receptor”(International Patent Application)

2021

EP 2 933 246 B1
"Versatile and functionalized intermediates for the synthesis of vitamin D and novel vitamin D derivatives" (European Patent)

DE 10 2013 107 885 A1
"Biokatalysator zur Produktion von 25-OH-Vitamin D3 und anderen hydroxylierten Vitamin D3 Derivaten mittels rekombinanter Bacillus megaterium Stämme" (German Patent Application)

EP 3 666 750 A1
"Crystalline form of bempedoic acid" (European Patent Application)

2019

US 9,994,508 B2
"Versatile and functionalized intermediates for the synthesis of vitamin D and novel vitamin D derivatives" (US-Patent)

Kontakt
Telefon +49 (0)681-3946-7570
E-Mail info@endotherm.de

Impressum
Datenschutz ­
Cookie-Einstellungen
AGB